Limbix (by BigHealth)
Evidence-based digital therapeutics for adolescent mental health and behavioral activation.
Precision medicine and pharmacogenomic intelligence for personalized therapeutic outcomes.
PersonalMed AI is a sophisticated clinical decision support system (CDSS) designed to bridge the gap between genomic data and pharmacological prescriptions. In the 2026 healthcare landscape, the platform operates as a centralized intelligence layer that integrates with Electronic Health Records (EHR) to provide real-time, patient-specific medication recommendations. Its technical architecture utilizes a proprietary Retrieval-Augmented Generation (RAG) framework, querying a curated database of clinical trials, PubMed citations, and FDA/EMA labeling in conjunction with a patient’s unique genetic markers. This allows clinicians to move beyond 'trial and error' prescribing, specifically in high-stakes fields like oncology, psychiatry, and cardiology. The platform utilizes advanced predictive modeling to forecast drug-drug interactions (DDIs) and adverse drug reactions (ADRs) based on metabolic phenotypes (e.g., CYP450 enzyme activity). Positioned as an enterprise-grade solution, PersonalMed AI emphasizes interoperability using HL7 FHIR standards, ensuring seamless data flow across hospital systems while maintaining strict HIPAA and GDPR compliance for sensitive health information.
Analyzes genomic variants (SNPs) to determine drug metabolism rates across 250+ standard medications.
Evidence-based digital therapeutics for adolescent mental health and behavioral activation.
Predictive clinical and operational intelligence to fight death and waste in healthcare.
Predictive medical data and clinical insights for streamlined enterprise underwriting.
The professional medical network for clinicians, providing HIPAA-compliant AI and telehealth solutions.
Verified feedback from the global deployment network.
Post queries, share implementation strategies, and help other users.
N-way interaction modeling that goes beyond binary pairs to analyze the cumulative effect of a 10+ drug regimen.
Predicts enzyme activity (e.g., CYP2D6) to adjust dosages dynamically based on the patient's biological capacity.
Reads patient history and writes recommendations directly back into the clinician's existing workflow.
Uses socio-economic and behavioral data to predict the likelihood of a patient skipping doses.
Calculates a percentage risk for specific side effects like nausea or QT prolongation based on comorbidities.
Maintains an immutable audit log of AI-driven recommendations for malpractice and insurance audit purposes.
Elderly patients often take multiple medications that interact poorly, leading to falls or cognitive decline.
Registry Updated:2/7/2026
Update EHR with pharmacist-approved plan.
Antidepressants often take weeks to show efficacy and frequently cause side effects, leading to treatment abandonment.
Chemotherapy drugs have narrow therapeutic windows and high toxicity.